Kun Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kun Peng has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Yue Zheng
MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti‐Infective Drug Development, IGCME, GBRCE for Functional Molecular Engineering School of Chemistry Sun Yat‐Sen University Guangzhou 510006 China
5 shared publications - Zong-Wan Mao
MOE Key Laboratory of Bioinorganic and Synthetic Chemistry IGCME, School of Chemistry, Sun Yat‐Sen University Guangzhou China
5 shared publications - Qian Cao
MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University, Guangzhou 510275, China
3 shared publications - Cai-Ping Tan
MOE Key Laboratory of Bioinorganic and Synthetic Chemistry School of Chemistry Sun Yat‐Sen University Guangzhou P. R. China
2 shared publications - Alexey A. Nazarov
Department of Chemistry, M.V. Lomonosov Moscow State University, 1/3 Leninskie Gory, 119991 Moscow, Russia
1 shared publication - Ananthu Rajan
Department of Life Sciences and Chemistry, Jacobs University, Campus Ring 1, 28759 Bremen, Germany
1 shared publication
Latest Publications
- 6 August 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (71)
AIE Photosensitizer‐Mediated Photodegradation of Carbonic Anhydrase IX Triggers Ferroptosis
To address hypoxia‐driven therapeutic resistance exacerbated by photodynamic therapy (PDT), targeted photodegradation of hypoxia‐inducible carbonic anhydrase IX (CAIX), an enzyme overexpressed on the tumor cell membrane, offers a direct countermeasure. Toward this goal, TBC was designed and synthesized as an aggregation‐induced emission photosensitizer (AIE PS) featuring a benzenesulfonamide tail for specifical CAIX targeting. Compared with the aniline‐modified TBN , the substitution with benzenesulfonamide endowed TBC with enhanced charge‐transfer characteristics, a more pronounced AIE effect, red‐shifted emission, and superior Type I/II PDT efficacy. TBC acted through selective CAIX binding and inhibition, an effect markedly amplified by its subsequent photodegradation, thereby promoting tumor‐specific accumulation while simultaneously alleviating hypoxia. Mechanistically, CAIX photodegradation synergistically mitigated hypoxia and induced intracellular acidosis, leading to elevated reactive oxygen species levels and lipid peroxidation that drove robust ferroptosis. Furthermore, TBC induced a spatiotemporal targeting cascade from the cell membrane to the Golgi apparatus and endoplasmic reticulum. The light‐induced stress at these sites potentiated ferroptosis and stimulated antitumor immunity. To our knowledge, this is the first AIE PS enabling in situ CAIX photodegradation to trigger ferroptosis via dual hypoxia alleviation and intracellular acidosis, offering a novel strategy against PDT resistance.
- 6 August 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (71)
AIE Photosensitizer‐Mediated Photodegradation of Carbonic Anhydrase IX Triggers Ferroptosis
To address hypoxia‐driven therapeutic resistance exacerbated by photodynamic therapy (PDT), targeted photodegradation of hypoxia‐inducible carbonic anhydrase IX (CAIX), an enzyme overexpressed on the tumor cell membrane, offers a direct countermeasure. Toward this goal, TBC was designed and synthesized as an aggregation‐induced emission photosensitizer (AIE PS) featuring a benzenesulfonamide tail for specifical CAIX targeting. Compared with the aniline‐modified TBN , the substitution with benzenesulfonamide endowed TBC with enhanced charge‐transfer characteristics, a more pronounced AIE effect, red‐shifted emission, and superior Type I/II PDT efficacy. TBC acted through selective CAIX binding and inhibition, an effect markedly amplified by its subsequent photodegradation, thereby promoting tumor‐specific accumulation while simultaneously alleviating hypoxia. Mechanistically, CAIX photodegradation synergistically mitigated hypoxia and induced intracellular acidosis, leading to elevated reactive oxygen species levels and lipid peroxidation that drove robust ferroptosis. Furthermore, TBC induced a spatiotemporal targeting cascade from the cell membrane to the Golgi apparatus and endoplasmic reticulum. The light‐induced stress at these sites potentiated ferroptosis and stimulated antitumor immunity. To our knowledge, this is the first AIE PS enabling in situ CAIX photodegradation to trigger ferroptosis via dual hypoxia alleviation and intracellular acidosis, offering a novel strategy against PDT resistance.
- 2 June 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (27)
Metal Complexes Stimulating Immunogenic Pyroptosis as Burgeoning Antitumor Strategy
The exploration of antitumor agents with diverse action mechanisms has become an important focus in both fundamental research and clinical oncology, driven by the need for more effective cancer therapies. Metal complexes, with their versatile chemical, photophysical, and biological properties, represent an ideal class of therapeutic and diagnostic candidates for investigating novel antitumor mechanisms. Recent advances have underscored their unique ability to trigger diverse cell death pathways. Among these, pyroptosis, an inflammatory form of programmed cell death, has garnered substantial attention because of its intrinsic link to antitumor immunity. This minireview focuses on the cutting‐edge developments in antitumor metal complexes designed to induce pyroptosis and elucidates their pyroptosis‐stimulating mechanisms across chemo‐, photo‐, sono‐ and targeted therapeutic modalities. By dissecting the interplay among pyroptosis induction, biological processes, such as inflammasome activation and gasdermin cleavage, and subsequent immune reprogramming, we provide a thorough overview of the action mechanisms of metal complex‐based pyroptosis inducers. This understanding has inspired the rational development of novel anticancer metal complexes that can remodel the tumor microenvironment and synergize with immunotherapies.
- 2 June 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (27)
Metal Complexes Stimulating Immunogenic Pyroptosis as Burgeoning Antitumor Strategy
The exploration of antitumor agents with diverse action mechanisms has become an important focus in both fundamental research and clinical oncology, driven by the need for more effective cancer therapies. Metal complexes, with their versatile chemical, photophysical, and biological properties, represent an ideal class of therapeutic and diagnostic candidates for investigating novel antitumor mechanisms. Recent advances have underscored their unique ability to trigger diverse cell death pathways. Among these, pyroptosis, an inflammatory form of programmed cell death, has garnered substantial attention because of its intrinsic link to antitumor immunity. This minireview focuses on the cutting‐edge developments in antitumor metal complexes designed to induce pyroptosis and elucidates their pyroptosis‐stimulating mechanisms across chemo‐, photo‐, sono‐ and targeted therapeutic modalities. By dissecting the interplay among pyroptosis induction, biological processes, such as inflammasome activation and gasdermin cleavage, and subsequent immune reprogramming, we provide a thorough overview of the action mechanisms of metal complex‐based pyroptosis inducers. This understanding has inspired the rational development of novel anticancer metal complexes that can remodel the tumor microenvironment and synergize with immunotherapies.
- 2 June 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (27) , e202507186
Metal Complexes Stimulating Immunogenic Pyroptosis as Burgeoning Antitumor Strategy
The exploration of antitumor agents with diverse action mechanisms has become an important focus in both fundamental research and clinical oncology, driven by the need for more effective cancer therapies. Metal complexes, with their versatile chemical, photophysical, and biological properties, represent an ideal class of therapeutic and diagnostic candidates for investigating novel antitumor mechanisms. Recent advances have underscored their unique ability to trigger diverse cell death pathways. Among these, pyroptosis, an inflammatory form of programmed cell death, has garnered substantial attention because of its intrinsic link to antitumor immunity. This minireview focuses on the cutting‐edge developments in antitumor metal complexes designed to induce pyroptosis and elucidates their pyroptosis‐stimulating mechanisms across chemo‐, photo‐, sono‐ and targeted therapeutic modalities. By dissecting the interplay among pyroptosis induction, biological processes, such as inflammasome activation and gasdermin cleavage, and subsequent immune reprogramming, we provide a thorough overview of the action mechanisms of metal complex‐based pyroptosis inducers. This understanding has inspired the rational development of novel anticancer metal complexes that can remodel the tumor microenvironment and synergize with immunotherapies.
- 2 June 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (27) , e202507186
Metal Complexes Stimulating Immunogenic Pyroptosis as Burgeoning Antitumor Strategy
The exploration of antitumor agents with diverse action mechanisms has become an important focus in both fundamental research and clinical oncology, driven by the need for more effective cancer therapies. Metal complexes, with their versatile chemical, photophysical, and biological properties, represent an ideal class of therapeutic and diagnostic candidates for investigating novel antitumor mechanisms. Recent advances have underscored their unique ability to trigger diverse cell death pathways. Among these, pyroptosis, an inflammatory form of programmed cell death, has garnered substantial attention because of its intrinsic link to antitumor immunity. This minireview focuses on the cutting‐edge developments in antitumor metal complexes designed to induce pyroptosis and elucidates their pyroptosis‐stimulating mechanisms across chemo‐, photo‐, sono‐ and targeted therapeutic modalities. By dissecting the interplay among pyroptosis induction, biological processes, such as inflammasome activation and gasdermin cleavage, and subsequent immune reprogramming, we provide a thorough overview of the action mechanisms of metal complex‐based pyroptosis inducers. This understanding has inspired the rational development of novel anticancer metal complexes that can remodel the tumor microenvironment and synergize with immunotherapies.
- Open Access
- 22 November 2024
- Published by Wiley in Advanced Science
- Vol. 12 (3) , e2411629
Ruthenium(II) Lipid‐Mimics Drive Lipid Phase Separation to Arouse Autophagy‐Ferroptosis Cascade for Photoimmunotherapy
Lipid‐mediated phase separation is crucial for the formation of lipophilic spontaneous domain to regulate lipid metabolism and homeostasis, furtherly contributing to multiple cell death pathways. Herein, a series of Ru(II) lipid‐mimics based on short chains or midchain lipids are developed. Among them, Ru‐LipM with two dodecyl chains significantly induces natural lipid phase separation via hydrocarbon chain‐melting phase transitions. Accompanied by the aggregation of Ru‐LipM‐labeled lipophilic membrane‐less compartments, most polyunsaturated lipids are increased and the autophagic flux is retarded with the adaptor protein sequestosome 1 (p62). Upon low‐dose irradiation, Ru‐LipM further drives ferritinophagy, providing an additional source of labile iron and rendering cells more sensitive to ferroptosis. Meanwhile, the peroxidation of polyunsaturated lipids occurs due to the deactivation of glutathione peroxidase 4 (GPX4) and the overexpression of acyl‐CoA synthetase long‐chain family member 4 (ACSL4), leading to the immunogenic ferroptosis. Ultimately, both innate and adaptive immunity are invigorated, indicating the tremendous antitumor capability of Ru‐LipM in vivo. This study presents an unprecedented discovery of small molecules capable of inducing and monitoring lipid phase separation, thereby eliciting robust immune responses in living cells. It provides a biosimulation strategy for constructing efficient metal‐based immune activators.
- 22 November 2024
- Published by Wiley in Advanced Science
- Vol. 12 (3) , e2411629
Open AccessRuthenium(II) Lipid‐Mimics Drive Lipid Phase Separation to Arouse Autophagy‐Ferroptosis Cascade for Photoimmunotherapy
Lipid‐mediated phase separation is crucial for the formation of lipophilic spontaneous domain to regulate lipid metabolism and homeostasis, furtherly contributing to multiple cell death pathways. Herein, a series of Ru(II) lipid‐mimics based on short chains or midchain lipids are developed. Among them, Ru‐LipM with two dodecyl chains significantly induces natural lipid phase separation via hydrocarbon chain‐melting phase transitions. Accompanied by the aggregation of Ru‐LipM‐labeled lipophilic membrane‐less compartments, most polyunsaturated lipids are increased and the autophagic flux is retarded with the adaptor protein sequestosome 1 (p62). Upon low‐dose irradiation, Ru‐LipM further drives ferritinophagy, providing an additional source of labile iron and rendering cells more sensitive to ferroptosis. Meanwhile, the peroxidation of polyunsaturated lipids occurs due to the deactivation of glutathione peroxidase 4 (GPX4) and the overexpression of acyl‐CoA synthetase long‐chain family member 4 (ACSL4), leading to the immunogenic ferroptosis. Ultimately, both innate and adaptive immunity are invigorated, indicating the tremendous antitumor capability of Ru‐LipM in vivo. This study presents an unprecedented discovery of small molecules capable of inducing and monitoring lipid phase separation, thereby eliciting robust immune responses in living cells. It provides a biosimulation strategy for constructing efficient metal‐based immune activators.
- Open Access
- 6 June 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 14 (25) , 6890-6903
Activation of the cGAS-STING pathway by a mitochondrial DNA-targeted emissive rhodium( iii ) metallointercalator
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon (STING) pathway is a key mediator of innate immunity involved in cancer development and treatment. The roles of mitochondrial DNA (mtDNA) in cancer immunotherapy have gradually emerged. Herein, we report a highly emissive rhodium(III) complex (Rh-Mito) as the mtDNA intercalator. Rh-Mito can specifically bind to mtDNA to cause the cytoplasmic release of mtDNA fragments to activate the cGAS-STING pathway. Moreover, Rh-Mito activates the mitochondrial retrograde signaling by disturbing the key metabolites involved in epigenetic modifications, which alters the nuclear genome methylation landscape to influence the expression of genes related to immune signaling pathways. Finally, we demonstrate that ferritin-encapsulated Rh-Mito elicits potent anticancer activities and evokes intense immune responses in vivo by intravenous injection. Overall, we report for the first time that small molecules targeting mtDNA can activate the cGAS-STING pathway, which gives insights into the development of biomacromolecule-targeted immunotherapeutic agents.
- 6 June 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 14 (25) , 6890-6903
Open AccessActivation of the cGAS-STING pathway by a mitochondrial DNA-targeted emissive rhodium( iii ) metallointercalator
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon (STING) pathway is a key mediator of innate immunity involved in cancer development and treatment. The roles of mitochondrial DNA (mtDNA) in cancer immunotherapy have gradually emerged. Herein, we report a highly emissive rhodium(III) complex (Rh-Mito) as the mtDNA intercalator. Rh-Mito can specifically bind to mtDNA to cause the cytoplasmic release of mtDNA fragments to activate the cGAS-STING pathway. Moreover, Rh-Mito activates the mitochondrial retrograde signaling by disturbing the key metabolites involved in epigenetic modifications, which alters the nuclear genome methylation landscape to influence the expression of genes related to immune signaling pathways. Finally, we demonstrate that ferritin-encapsulated Rh-Mito elicits potent anticancer activities and evokes intense immune responses in vivo by intravenous injection. Overall, we report for the first time that small molecules targeting mtDNA can activate the cGAS-STING pathway, which gives insights into the development of biomacromolecule-targeted immunotherapeutic agents.
- Top Cited Papers
- 4 April 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 52 (8) , 2790-2832
Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
Organometallics act through specific biomolecular targets or tumor homeostasis perturbation to induce various cell death pathways.
- 4 April 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 52 (8) , 2790-2832
Top Cited PapersOrganometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
Organometallics act through specific biomolecular targets or tumor homeostasis perturbation to induce various cell death pathways.
- Open Access
- 8 June 2022
- Published by Impact Journals, LLC in Aging
- Vol. 14 (11) , 4839-4857
Identification of biomarkers for immunotherapy response in prostate cancer and potential drugs to alleviate immunosuppression
Background: Immunotherapy has a significant effect on the treatment of many tumor types. However, prostate cancers generally fail to show significant responses to immunotherapy owing to their immunosuppressive microenvironments. To sustain progress towards more effective immunotherapy for prostate cancer, comprehensive analyses of the genetic characteristics of the immune microenvironment and novel therapeutic strategies are required. Methods: The transcriptome profiles of patients with prostate cancer were obtained from GEO and processed with the TIDE algorithm to predict their responses to immunotherapy. Next, the significant differentially expressed genes (DEGs) between the responder and non-responder groups were identified and used to compute the co-expression modules by WGCNA. Then, co-expression networks were constructed and survival analysis was applied to hub genes. Finally, drug candidates to alleviate immunosuppression were filtered in prostate cancer using GSEA based on hub genes. Results: In total, we identified 2758 significant DEGs and constructed 16 co-expression modules, seven of which were significantly correlated with the immune response score. In total, 133 hub genes were identified, of which 13 were significantly associated with prostate cancer prognosis. Co-expression networks of hub genes were constructed with KMT2B at the center. Finally, six candidate drugs for prostate cancer immunotherapy were identified in PC3 and LNCaP cell lines. Conclusions: We obtained datasets from multiple platforms, performed integrated bioinformatic analysis to identify 133 hub genes and 13 biomarkers of an immunotherapy response, and six candidate drugs were filtered to inhibit the immunosuppressive tumor microenvironment, to ultimately improve patient responses to immunotherapy in prostate cancer.
- 8 June 2022
- Published by Impact Journals, LLC in Aging
- Vol. 14 (11) , 4839-4857
Open AccessIdentification of biomarkers for immunotherapy response in prostate cancer and potential drugs to alleviate immunosuppression
Background: Immunotherapy has a significant effect on the treatment of many tumor types. However, prostate cancers generally fail to show significant responses to immunotherapy owing to their immunosuppressive microenvironments. To sustain progress towards more effective immunotherapy for prostate cancer, comprehensive analyses of the genetic characteristics of the immune microenvironment and novel therapeutic strategies are required. Methods: The transcriptome profiles of patients with prostate cancer were obtained from GEO and processed with the TIDE algorithm to predict their responses to immunotherapy. Next, the significant differentially expressed genes (DEGs) between the responder and non-responder groups were identified and used to compute the co-expression modules by WGCNA. Then, co-expression networks were constructed and survival analysis was applied to hub genes. Finally, drug candidates to alleviate immunosuppression were filtered in prostate cancer using GSEA based on hub genes. Results: In total, we identified 2758 significant DEGs and constructed 16 co-expression modules, seven of which were significantly correlated with the immune response score. In total, 133 hub genes were identified, of which 13 were significantly associated with prostate cancer prognosis. Co-expression networks of hub genes were constructed with KMT2B at the center. Finally, six candidate drugs for prostate cancer immunotherapy were identified in PC3 and LNCaP cell lines. Conclusions: We obtained datasets from multiple platforms, performed integrated bioinformatic analysis to identify 133 hub genes and 13 biomarkers of an immunotherapy response, and six candidate drugs were filtered to inhibit the immunosuppressive tumor microenvironment, to ultimately improve patient responses to immunotherapy in prostate cancer.
- Open Access
- 23 November 2021
- Published by Wiley in Chemistry – A European Journal
- Vol. 27 (71) , 17928-17940
Metallodrug Profiling against SARS‐CoV‐2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain‐like Protease PLpro
The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has called for an urgent need for dedicated antiviral therapeutics. Metal complexes are commonly underrepresented in compound libraries that are used for screening in drug discovery campaigns, however, there is growing evidence for their role in medicinal chemistry. Based on previous results, we have selected more than 100 structurally diverse metal complexes for profiling as inhibitors of two relevant SARS‐CoV‐2 replication mechanisms, namely the interaction of the spike (S) protein with the ACE2 receptor and the papain‐like protease PLpro. In addition to many well‐established types of mononuclear experimental metallodrugs, the pool of compounds tested was extended to approved metal‐based therapeutics such as silver sulfadiazine and thiomersal, as well as polyoxometalates (POMs). Among the mononuclear metal complexes, only a small number of active inhibitors of the S/ACE2 interaction was identified, with titanocene dichloride as the only strong inhibitor. However, among the gold and silver containing complexes many turned out to be very potent inhibitors of PLpro activity. Highly promising activity against both targets was noted for many POMs. Selected complexes were evaluated in antiviral SARS‐CoV‐2 assays confirming activity for gold complexes with N‐heterocyclic carbene (NHC) or dithiocarbamato ligands, a silver NHC complex, titanocene dichloride as well as a POM compound. These studies might provide starting points for the design of metal‐based SARS‐CoV‐2 antiviral agents.
- 23 November 2021
- Published by Wiley in Chemistry – A European Journal
- Vol. 27 (71) , 17928-17940
Open AccessMetallodrug Profiling against SARS‐CoV‐2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain‐like Protease PLpro
The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has called for an urgent need for dedicated antiviral therapeutics. Metal complexes are commonly underrepresented in compound libraries that are used for screening in drug discovery campaigns, however, there is growing evidence for their role in medicinal chemistry. Based on previous results, we have selected more than 100 structurally diverse metal complexes for profiling as inhibitors of two relevant SARS‐CoV‐2 replication mechanisms, namely the interaction of the spike (S) protein with the ACE2 receptor and the papain‐like protease PLpro. In addition to many well‐established types of mononuclear experimental metallodrugs, the pool of compounds tested was extended to approved metal‐based therapeutics such as silver sulfadiazine and thiomersal, as well as polyoxometalates (POMs). Among the mononuclear metal complexes, only a small number of active inhibitors of the S/ACE2 interaction was identified, with titanocene dichloride as the only strong inhibitor. However, among the gold and silver containing complexes many turned out to be very potent inhibitors of PLpro activity. Highly promising activity against both targets was noted for many POMs. Selected complexes were evaluated in antiviral SARS‐CoV‐2 assays confirming activity for gold complexes with N‐heterocyclic carbene (NHC) or dithiocarbamato ligands, a silver NHC complex, titanocene dichloride as well as a POM compound. These studies might provide starting points for the design of metal‐based SARS‐CoV‐2 antiviral agents.
- 1 June 2010
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 10636919,p. 1126-1132
Geometric properties of multiple reflections in catadioptric camera with two planar mirrors
A catadioptric system consisting of a pinhole camera and two planar mirrors is deeply investigated in this paper. The two mirrors combine to form a corner and face-to-face with the pinhole. Their relative pose is unknown. An object will be reflected in the mirror corner one-time or multiple-times. Using the pinhole, we may take an image containing the object and its reflections, i.e., simultaneously imaging multiple views of an object by a single camera. We discovered that each 3D point and its reflections lie on a circle. We call the point set composed of a 3D point and its reflections, a Reflection Point Group (RPG), and the circle related to a RPG is called a RPG circle. All RPG circles are parallel to one another. Furthermore, each RPG can be partitioned into two separate subgroups. Shape formed by all points in a subgroup is invariant with respect to location of the 3D point. From these geometric properties, two calibration approaches can be utilized: One is based on parallel circles; the other is using 2D homographies among invariant shapes. Experiments validate our approaches.
- 1 June 2010
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 10636919,p. 1126-1132
Geometric properties of multiple reflections in catadioptric camera with two planar mirrors
A catadioptric system consisting of a pinhole camera and two planar mirrors is deeply investigated in this paper. The two mirrors combine to form a corner and face-to-face with the pinhole. Their relative pose is unknown. An object will be reflected in the mirror corner one-time or multiple-times. Using the pinhole, we may take an image containing the object and its reflections, i.e., simultaneously imaging multiple views of an object by a single camera. We discovered that each 3D point and its reflections lie on a circle. We call the point set composed of a 3D point and its reflections, a Reflection Point Group (RPG), and the circle related to a RPG is called a RPG circle. All RPG circles are parallel to one another. Furthermore, each RPG can be partitioned into two separate subgroups. Shape formed by all points in a subgroup is invariant with respect to location of the 3D point. From these geometric properties, two calibration approaches can be utilized: One is based on parallel circles; the other is using 2D homographies among invariant shapes. Experiments validate our approaches.